Sebelius Kathleen bought HUMA
May 19, 2026 · Form 4 insider transaction
Sebelius Kathleen bought 56,818 shares of Humacyte, Inc. at $0.88 per share, a transaction worth $50.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
56,818
Price
$0.88
Total value
$50.0K
InsiderSebelius Kathleen
RoleDirector
CompanyHumacyte, Inc. (HUMA)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 19, 2026
Filing dateMay 20, 2026
Shares owned after148,025
OwnershipDirect
10b5-1 planNo
AmendedNo